bioMérieux, founded in 1963, is a global leader in in vitro diagnostics, specializing in the development, manufacturing, and marketing of diagnostic solutions for clinical and industrial applications. The company acquired Invisible Sentinel Inc. in 2019, integrating its innovative molecular diagnostic tools for rapid detection of pathogens and spoilage organisms in food and beverage industries. bioMérieux operates in over 160 countries, providing diagnostic solutions that improve patient health and ensure consumer safety.